Clinical trials for anal cancer
33 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Anal cancer
#NCT02628067
Locally Advanced
Metastatic
MSI/dMMR
Immunotherapy
Systemic Treatment-Naive
Immunotherapy
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Merck Sharp & Dohme LLC
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT02611024
Neuroendocrine tumor
Locally Advanced
Metastatic
Chemotherapy
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif)
PharmaMar
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT04585750
Locally Advanced
Metastatic
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux) (and 2 more...)
PMV Pharmaceuticals, Inc
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT04954820
Neuroendocrine tumor
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Jean Perrin (Clermont Ferrand ), Institut du cancer de Montpellier (Montpellier), Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest) (and 22 more...)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05751798
MSI/dMMR
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
Systemic Treatment-Naive
Immunotherapy
Systemic Treatment-Naive
Immunotherapy
Centre Léon Bérard (Lyon)
OSE Immunotherapeutics
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05384626
Locally Advanced
Metastatic
Metastatic Castration-resistant
Other mutation
BRAF
MET
HER2
RET
NTRK-1/2/3
KRAS G12C
KRAS non G12C
BRCA 1/2
AKT
PIK3CA
PALB2
ESR
FGFR
PTEN
MSI/dMMR
ATM
CDK12
HOXB13
CHEK 1/2
NRAS
Systemic Treatment-Naive
Gustave Roussy (Villejuif), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Nuvalent Inc.
Phase 2
Anal cancer
#NCT04894370
Other
Metastatic
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Besançon (Besançon), Hôpital Nord de Franche Comté (Trévenans), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Institut National du Cancer, France
Phase 1
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Phase 1
Hôpital Pitié Salpêtrière - AP-HP (Paris)